Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-01

FDA Approved: ZEGERID OTC — Supplemental Application (Riley Consumer Care LLC)

View source ↗

Summary

FDA approved a supplemental application for ZEGERID OTC by Riley Consumer Care LLC. The product contains omeprazole sodium bicarbonate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZEGERID OTC (omeprazole sodium bicarbonate)

Snippet

SUPPL AP for ZEGERID OTC (OMEPRAZOLE, SODIUM BICARBONATE)